Latest News

Tuesday, January 27, 2015 | Medical Studies

Slight Posterior Corneal Protrusion After LASIK and PRK

Femtosecond laser-assisted LASIK and photorefractive keratectomy (PRK) are both associated with mild but statistically significant forward protrusion of the posterior cornea. According to results from…

Read the full story

Tuesday, January 27, 2015 | Abbott Medical Optics

Toric Lens May Improve Astigmatism After Cataract Removal

The Tecnis IOL (Abbott Medical Optics) significantly improved vision in astigmatic eyes, sharpened uncorrected vision, and proved rotationally stable after lens implantation with cataract removal in p…

Read the full story

Tuesday, January 27, 2015 | Retina, Psivida

pSivida Reports Iluvien Receives Marketing Authorization in Two More EU Countries

pSivida Corp. announced that Finland and Luxembourg have granted marketing authorization to Iluvien for the treatment of vision impairment associated with chronic diabetic macular edema (DME) consider…

Read the full story

Tuesday, January 27, 2015 | Management/Leadership

Robert Califf, MD, Named FDA Deputy Commissioner for Medical Products and Tobacco

U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, MD, appointed Robert Califf, MD, a leader in cardiology, clinical research, and medical economics, as FDA Deputy Commissioner for Me…

Read the full story

Tuesday, January 27, 2015 | Product Releases

New Eye Scan Predicts Peripheral Neuropathy in Diabetes

Corneal confocal microscopy (CCM) predicts incipient peripheral neuropathy in patients with type 1 diabetes, a new study finds. The technique involves the examination of unmyelinated nerve fibers at h…

Read the full story

Monday, January 26, 2015 | FDA Approval/Clearance, Abbott Medical Optics

Abbott Receives FDA Clearance for the Creation of Intracorneal Pockets With the iFS Femtosecond Laser System

Abbott Medical Optics (AMO) announced FDA clearance for the creation of intracorneal pockets with the iFS Advanced Femtosecond Laser System, according to a company news release. The iFS software will …

Read the full story

Monday, January 26, 2015 | CE Mark Approval

Neurostim Dry Eye Startup Backed by Kleiner Perkins, NEA Readies for CE Mark

Dry eye implant maker Oculeve is working toward a CE mark with its venture round from last spring. It's also in the process of recruiting for an initial U.S. clinical trial; the trial started in D…

Read the full story

Monday, January 26, 2015 | Acquisitions/Mergers, Haag Streit, Optovue

Haag-Streit UK Appointed Sole Distributor of the Optovue Portfolio in the UK

Haag-Streit UK (HS-UK) has announced that it will be appointed sole distributor of the Optovue product portfolio in the UK beginning February 4, according to a company news release. HS-UK will be taki…

Read the full story

Monday, January 26, 2015 | Retina, Bayer, Regeneron Pharmaceuticals

Eylea Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to CRVO or BRVO in the European Union

Regeneron Pharmaceuticals announced that Eylea (aflibercept) injection has been recommended for approval by the European Committee for Medicinal Products for Human Use (CHMP) for the treatment of visu…

Read the full story

Monday, January 26, 2015 | Management/Leadership

Nightstar Announces an Increased Investment to £17m and Appoints a New Chief Executive Officer

NightstaRx announced an increase in its funding to £17 million to expedite the company’s clinical choroideremia program, according to a company news release. The funding has come from the …

Read the full story

Monday, January 26, 2015 | Retina

Hanmi Invests $20M in Allegro and Licenses Its AMD, DME and VMT Therapy in Korea and China

Allegro Ophthalmics and Hanmi Pharmaceuticals have entered into a license agreement for Luminate (ALG-1001), Allegro’s Integrin Peptide Therapy, in The Republic of Korea and the People’s R…

Read the full story

Monday, January 26, 2015 | Medical Studies

Gene Discovered That is Tied to Profound Vision Loss

An exhaustive hereditary analysis of a large Louisiana family with vision issues has uncovered a new gene tied to an incurable eye disorder called retinitis pigmentosa, according to an examination led…

Read the full story

Friday, January 23, 2015 | Retina

The UK’s Leading Blindness Organizations Come Together at House of Commons to Call for Better Funding, Screening, and Treatment for Macular Degeneration

The AMD Alliance International led an event at the House of Commons that addressed the current issues the NHS is facing with diagnosing, treating, and managing the growing number of ageing people affe…

Read the full story

Friday, January 23, 2015 | Management/Leadership, Allergan, Valeant Ophthalmics

Valeant Chief Pearson Admits 'Miscalculation' in Allergan Pursuit

Regrets? Valeant’s chief executive, Mike Pearson, has a few. Eight weeks have passed since his pharmaceuticals group lost out in the race to buy Allergan, and Mr Pearson is remarkably candid abo…

Read the full story

Friday, January 23, 2015 | Clinical Trials, Ocular Therapeutix

Ocular Therapeutix Enrolls First Patient in Phase 2 Clinical Trial for Sustained-Release Dexamethasone for the Treatment of Dry Eye Disease

Ocular Therapeutix announced enrollment of the first patient in a phase 2 clinical trial to evaluate the safety and efficacy of sustained-release dexamethasone (OTX-DP), an ophthalmic corticosteroid f…

Read the full story
Load More